Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.

MLA

Greulich, Timm, et al. “Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.” International Journal of COPD, vol. 17, Jan. 2022, pp. 53–64. EBSCOhost, https://doi.org/10.2147/COPD.S346051.

APA

Greulich, T., Albert, A., Cassel, W., Boeselt, T., Peychev, E., Klemmer, A., Ferreira, F., Clarenbach, C., Torres-Duran, M. L., Turner, A. M., & Miravitlles, M. (2022). Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. International Journal of COPD, 17, 53–64. https://doi.org/10.2147/COPD.S346051

Chicago

Greulich, Timm, Anna Albert, Werner Cassel, Tobias Boeselt, Erika Peychev, Andreas Klemmer, Francini Ferreira, et al. 2022. “Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.” International Journal of COPD 17 (January): 53–64. doi:10.2147/COPD.S346051.